HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-MAY-15 4ZLO
TITLE SERINE/THREONINE-PROTEIN KINASE PAK1 COMPLEXED WITH A
TITLE 2 DIBENZODIAZEPINE: IDENTIFICATION OF AN ALLOSTERIC SITE ON PAK1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 1;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: ALPHA-PAK,P21-ACTIVATED KINASE 1,PAK-1,P65-PAK;
COMPND 5 EC: 2.7.11.1;
COMPND 6 ENGINEERED: YES;
COMPND 7 OTHER_DETAILS: RESIDUE 177 IS PHOSPHORYLATED THREONINE
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PAK1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS DIBENZODAZEPINE, PAK1, KINASE, ALLOSTERIC INHIBITOR, TRANSFERASE-
KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR C.R.BELLAMACINA,D.E.BUSSIERE
REVDAT 2 23-OCT-24 4ZLO 1 REMARK
REVDAT 1 05-AUG-15 4ZLO 0
JRNL AUTH A.S.KARPOV,P.AMIRI,C.BELLAMACINA,M.H.BELLANCE,
JRNL AUTH 2 W.BREITENSTEIN,D.DANIEL,R.DENAY,D.FABBRO,C.FERNANDEZ,
JRNL AUTH 3 I.GALUBA,S.GUERRO-LAGASSE,S.GUTMANN,L.HINH,W.JAHNKE,J.KLOPP,
JRNL AUTH 4 A.LAI,M.K.LINDVALL,S.MA,H.MOBITZ,S.PECCHI,G.RUMMEL,
JRNL AUTH 5 K.SHOEMAKER,J.TRAPPE,C.VOLIVA,S.W.COWAN-JACOB,A.L.MARZINZIK
JRNL TITL OPTIMIZATION OF A DIBENZODIAZEPINE HIT TO A POTENT AND
JRNL TITL 2 SELECTIVE ALLOSTERIC PAK1 INHIBITOR.
JRNL REF ACS MED.CHEM.LETT. V. 6 776 2015
JRNL REFN ISSN 1948-5875
JRNL PMID 26191365
JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00102
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.4
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.31
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 3 NUMBER OF REFLECTIONS : 21368
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.196
REMARK 3 R VALUE (WORKING SET) : 0.195
REMARK 3 FREE R VALUE : 0.222
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060
REMARK 3 FREE R VALUE TEST SET COUNT : 1081
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 11
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.62
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2668
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2125
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2545
REMARK 3 BIN R VALUE (WORKING SET) : 0.2094
REMARK 3 BIN FREE R VALUE : 0.2800
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.61
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 123
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4083
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 30
REMARK 3 SOLVENT ATOMS : 121
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 64.10
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.70
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -2.55140
REMARK 3 B22 (A**2) : -1.92110
REMARK 3 B33 (A**2) : 4.47250
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -7.53590
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.315
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.459
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.243
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.477
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.248
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 4182 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 5674 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1429 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 94 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 616 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 4182 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 581 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : 1 ; 1.000 ; HARMONIC
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 4808 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.13
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.82
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.01
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 32.1159 5.1771 -14.5141
REMARK 3 T TENSOR
REMARK 3 T11: -0.1117 T22: -0.1162
REMARK 3 T33: -0.1139 T12: -0.0430
REMARK 3 T13: 0.0110 T23: 0.0036
REMARK 3 L TENSOR
REMARK 3 L11: 1.3221 L22: 2.0107
REMARK 3 L33: 2.0864 L12: -0.6516
REMARK 3 L13: -0.6135 L23: -0.4407
REMARK 3 S TENSOR
REMARK 3 S11: 0.0182 S12: 0.2234 S13: 0.0221
REMARK 3 S21: -0.1094 S22: -0.0894 S23: -0.1582
REMARK 3 S31: 0.1047 S32: -0.0706 S33: 0.0712
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: { B|* }
REMARK 3 ORIGIN FOR THE GROUP (A): -1.8321 0.9761 13.3558
REMARK 3 T TENSOR
REMARK 3 T11: -0.1796 T22: -0.1233
REMARK 3 T33: -0.2129 T12: -0.0661
REMARK 3 T13: 0.0196 T23: -0.0205
REMARK 3 L TENSOR
REMARK 3 L11: 3.3059 L22: 2.6534
REMARK 3 L33: 3.0827 L12: -0.3145
REMARK 3 L13: -1.2150 L23: -0.5203
REMARK 3 S TENSOR
REMARK 3 S11: -0.1795 S12: 0.1178 S13: -0.3218
REMARK 3 S21: 0.0255 S22: 0.0012 S23: 0.2681
REMARK 3 S31: -0.0143 S32: -0.4136 S33: 0.1783
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4ZLO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-15.
REMARK 100 THE DEPOSITION ID IS D_1000209430.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-JAN-09
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21368
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500
REMARK 200 RESOLUTION RANGE LOW (A) : 62.500
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 200 DATA REDUNDANCY : 3.200
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77
REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0
REMARK 200 DATA REDUNDANCY IN SHELL : 2.90
REMARK 200 R MERGE FOR SHELL (I) : 0.41500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.94
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 22-27% PEG3350, 500-700MM NACL, 100MM
REMARK 280 BIS-TRIS, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.67000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1520 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 25640 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 20.45001
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -62.52991
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 950 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 26210 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A 249
REMARK 465 GLY A 279
REMARK 465 ALA A 280
REMARK 465 LEU A 303
REMARK 465 GLN A 304
REMARK 465 GLN A 305
REMARK 465 GLN A 306
REMARK 465 PRO A 307
REMARK 465 PHE A 410
REMARK 465 CYS A 411
REMARK 465 ALA A 412
REMARK 465 GLN A 413
REMARK 465 ILE A 414
REMARK 465 THR A 415
REMARK 465 PRO A 416
REMARK 465 GLU A 417
REMARK 465 GLN A 418
REMARK 465 ASN A 544
REMARK 465 HIS A 545
REMARK 465 SER B 249
REMARK 465 ASP B 250
REMARK 465 GLU B 251
REMARK 465 GLU B 252
REMARK 465 GLY B 264
REMARK 465 ASP B 265
REMARK 465 PRO B 266
REMARK 465 GLY B 279
REMARK 465 ALA B 280
REMARK 465 SER B 281
REMARK 465 GLY B 282
REMARK 465 THR B 283
REMARK 465 ASP B 289
REMARK 465 VAL B 290
REMARK 465 ALA B 291
REMARK 465 THR B 292
REMARK 465 ASN B 302
REMARK 465 LEU B 303
REMARK 465 GLN B 304
REMARK 465 GLN B 305
REMARK 465 GLN B 306
REMARK 465 PRO B 307
REMARK 465 LYS B 308
REMARK 465 LYS B 309
REMARK 465 LEU B 335
REMARK 465 VAL B 336
REMARK 465 GLY B 337
REMARK 465 ASP B 338
REMARK 465 GLU B 339
REMARK 465 LEU B 340
REMARK 465 TRP B 341
REMARK 465 ASN B 544
REMARK 465 HIS B 545
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASP A 250 CG OD1 OD2
REMARK 470 GLU A 251 CG CD OE1 OE2
REMARK 470 GLU A 252 CG CD OE1 OE2
REMARK 470 ILE A 253 CG1 CG2 CD1
REMARK 470 LEU A 254 CG CD1 CD2
REMARK 470 GLU A 255 CG CD OE1 OE2
REMARK 470 LYS A 256 CG CD CE NZ
REMARK 470 GLU A 274 CG CD OE1 OE2
REMARK 470 GLN A 278 CG CD OE1 NE2
REMARK 470 LYS A 308 CG CD CE NZ
REMARK 470 LYS A 309 CG CD CE NZ
REMARK 470 GLU A 310 CG CD OE1 OE2
REMARK 470 LEU A 311 CG CD1 CD2
REMARK 470 VAL A 336 CG1 CG2
REMARK 470 ASP A 338 CG OD1 OD2
REMARK 470 GLN A 384 CG CD OE1 NE2
REMARK 470 VAL A 425 CG1 CG2
REMARK 470 GLU A 461 CG CD OE1 OE2
REMARK 470 ASN A 466 CG OD1 ND2
REMARK 470 GLU A 483 CG CD OE1 OE2
REMARK 470 GLN A 485 CG CD OE1 NE2
REMARK 470 GLU A 488 CG CD OE1 OE2
REMARK 470 LYS A 489 CG CD CE NZ
REMARK 470 LYS A 542 CG CD CE NZ
REMARK 470 ASN A 543 CG OD1 ND2
REMARK 470 GLU B 255 CG CD OE1 OE2
REMARK 470 LEU B 257 CG CD1 CD2
REMARK 470 ARG B 258 CG CD NE CZ NH1 NH2
REMARK 470 LYS B 267 CG CD CE NZ
REMARK 470 LYS B 268 CG CD CE NZ
REMARK 470 LYS B 269 CG CD CE NZ
REMARK 470 ARG B 272 CG CD NE CZ NH1 NH2
REMARK 470 GLU B 274 CG CD OE1 OE2
REMARK 470 LYS B 275 CG CD CE NZ
REMARK 470 GLN B 278 CG CD OE1 NE2
REMARK 470 MET B 288 CG SD CE
REMARK 470 GLN B 294 CG CD OE1 NE2
REMARK 470 GLU B 295 CG CD OE1 OE2
REMARK 470 LYS B 299 CG CD CE NZ
REMARK 470 MET B 301 CG SD CE
REMARK 470 GLU B 310 CG CD OE1 OE2
REMARK 470 LEU B 311 CG CD1 CD2
REMARK 470 GLU B 417 CG CD OE1 OE2
REMARK 470 GLN B 418 CG CD OE1 NE2
REMARK 470 GLU B 507 CG CD OE1 OE2
REMARK 470 LYS B 508 CD CE NZ
REMARK 470 GLN B 519 CG CD OE1 NE2
REMARK 470 LYS B 522 CG CD CE NZ
REMARK 470 ASN B 543 CG OD1 ND2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 388 -16.11 80.12
REMARK 500 ASP A 407 -83.67 -146.97
REMARK 500 PHE A 408 -28.03 75.06
REMARK 500 LYS B 256 22.64 -74.47
REMARK 500 ASP B 389 47.64 -149.60
REMARK 500 ASP B 407 83.71 60.63
REMARK 500 ASP B 407 83.44 61.11
REMARK 500 GLN B 418 75.17 -154.98
REMARK 500 PRO B 428 -52.52 -27.89
REMARK 500 THR B 541 51.73 -97.91
REMARK 500 LYS B 542 35.22 -94.40
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 4PV A 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 602
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4ZJJ RELATED DB: PDB
REMARK 900 4ZJJ CONTAINS THE SAME PROTEIN COMPLEXED WITH AN ANALOG
REMARK 900 RELATED ID: 4ZJI RELATED DB: PDB
REMARK 900 4ZJJ CONTAINS THE SAME PROTEIN COMPLEXED WITH AN ANALOG
DBREF 4ZLO A 249 545 UNP Q13153 PAK1_HUMAN 249 545
DBREF 4ZLO B 249 545 UNP Q13153 PAK1_HUMAN 249 545
SEQRES 1 A 297 SER ASP GLU GLU ILE LEU GLU LYS LEU ARG SER ILE VAL
SEQRES 2 A 297 SER VAL GLY ASP PRO LYS LYS LYS TYR THR ARG PHE GLU
SEQRES 3 A 297 LYS ILE GLY GLN GLY ALA SER GLY THR VAL TYR THR ALA
SEQRES 4 A 297 MET ASP VAL ALA THR GLY GLN GLU VAL ALA ILE LYS GLN
SEQRES 5 A 297 MET ASN LEU GLN GLN GLN PRO LYS LYS GLU LEU ILE ILE
SEQRES 6 A 297 ASN GLU ILE LEU VAL MET ARG GLU ASN LYS ASN PRO ASN
SEQRES 7 A 297 ILE VAL ASN TYR LEU ASP SER TYR LEU VAL GLY ASP GLU
SEQRES 8 A 297 LEU TRP VAL VAL MET GLU TYR LEU ALA GLY GLY SER LEU
SEQRES 9 A 297 THR ASP VAL VAL THR GLU THR CYS MET ASP GLU GLY GLN
SEQRES 10 A 297 ILE ALA ALA VAL CYS ARG GLU CYS LEU GLN ALA LEU GLU
SEQRES 11 A 297 PHE LEU HIS SER ASN GLN VAL ILE HIS ARG ASP ILE LYS
SEQRES 12 A 297 SER ASP ASN ILE LEU LEU GLY MET ASP GLY SER VAL LYS
SEQRES 13 A 297 LEU THR ASP PHE GLY PHE CYS ALA GLN ILE THR PRO GLU
SEQRES 14 A 297 GLN SER LYS ARG SER TPO MET VAL GLY THR PRO TYR TRP
SEQRES 15 A 297 MET ALA PRO GLU VAL VAL THR ARG LYS ALA TYR GLY PRO
SEQRES 16 A 297 LYS VAL ASP ILE TRP SER LEU GLY ILE MET ALA ILE GLU
SEQRES 17 A 297 MET ILE GLU GLY GLU PRO PRO TYR LEU ASN GLU ASN PRO
SEQRES 18 A 297 LEU ARG ALA LEU TYR LEU ILE ALA THR ASN GLY THR PRO
SEQRES 19 A 297 GLU LEU GLN ASN PRO GLU LYS LEU SER ALA ILE PHE ARG
SEQRES 20 A 297 ASP PHE LEU ASN ARG CYS LEU GLU MET ASP VAL GLU LYS
SEQRES 21 A 297 ARG GLY SER ALA LYS GLU LEU LEU GLN HIS GLN PHE LEU
SEQRES 22 A 297 LYS ILE ALA LYS PRO LEU SER SER LEU THR PRO LEU ILE
SEQRES 23 A 297 ALA ALA ALA LYS GLU ALA THR LYS ASN ASN HIS
SEQRES 1 B 297 SER ASP GLU GLU ILE LEU GLU LYS LEU ARG SER ILE VAL
SEQRES 2 B 297 SER VAL GLY ASP PRO LYS LYS LYS TYR THR ARG PHE GLU
SEQRES 3 B 297 LYS ILE GLY GLN GLY ALA SER GLY THR VAL TYR THR ALA
SEQRES 4 B 297 MET ASP VAL ALA THR GLY GLN GLU VAL ALA ILE LYS GLN
SEQRES 5 B 297 MET ASN LEU GLN GLN GLN PRO LYS LYS GLU LEU ILE ILE
SEQRES 6 B 297 ASN GLU ILE LEU VAL MET ARG GLU ASN LYS ASN PRO ASN
SEQRES 7 B 297 ILE VAL ASN TYR LEU ASP SER TYR LEU VAL GLY ASP GLU
SEQRES 8 B 297 LEU TRP VAL VAL MET GLU TYR LEU ALA GLY GLY SER LEU
SEQRES 9 B 297 THR ASP VAL VAL THR GLU THR CYS MET ASP GLU GLY GLN
SEQRES 10 B 297 ILE ALA ALA VAL CYS ARG GLU CYS LEU GLN ALA LEU GLU
SEQRES 11 B 297 PHE LEU HIS SER ASN GLN VAL ILE HIS ARG ASP ILE LYS
SEQRES 12 B 297 SER ASP ASN ILE LEU LEU GLY MET ASP GLY SER VAL LYS
SEQRES 13 B 297 LEU THR ASP PHE GLY PHE CYS ALA GLN ILE THR PRO GLU
SEQRES 14 B 297 GLN SER LYS ARG SER TPO MET VAL GLY THR PRO TYR TRP
SEQRES 15 B 297 MET ALA PRO GLU VAL VAL THR ARG LYS ALA TYR GLY PRO
SEQRES 16 B 297 LYS VAL ASP ILE TRP SER LEU GLY ILE MET ALA ILE GLU
SEQRES 17 B 297 MET ILE GLU GLY GLU PRO PRO TYR LEU ASN GLU ASN PRO
SEQRES 18 B 297 LEU ARG ALA LEU TYR LEU ILE ALA THR ASN GLY THR PRO
SEQRES 19 B 297 GLU LEU GLN ASN PRO GLU LYS LEU SER ALA ILE PHE ARG
SEQRES 20 B 297 ASP PHE LEU ASN ARG CYS LEU GLU MET ASP VAL GLU LYS
SEQRES 21 B 297 ARG GLY SER ALA LYS GLU LEU LEU GLN HIS GLN PHE LEU
SEQRES 22 B 297 LYS ILE ALA LYS PRO LEU SER SER LEU THR PRO LEU ILE
SEQRES 23 B 297 ALA ALA ALA LYS GLU ALA THR LYS ASN ASN HIS
MODRES 4ZLO TPO A 423 THR MODIFIED RESIDUE
MODRES 4ZLO TPO B 423 THR MODIFIED RESIDUE
HET TPO A 423 11
HET TPO B 423 11
HET 4PV A 601 24
HET GOL A 602 6
HETNAM TPO PHOSPHOTHREONINE
HETNAM 4PV 2,8-DIFLUORO-11-(4-METHYLPIPERAZIN-1-YL)-5H-DIBENZO[B,
HETNAM 2 4PV E][1,4]DIAZEPINE
HETNAM GOL GLYCEROL
HETSYN TPO PHOSPHONOTHREONINE
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 1 TPO 2(C4 H10 N O6 P)
FORMUL 3 4PV C18 H18 F2 N4
FORMUL 4 GOL C3 H8 O3
FORMUL 5 HOH *121(H2 O)
HELIX 1 AA1 ASP A 250 VAL A 261 1 12
HELIX 2 AA2 ASP A 265 LYS A 269 1 5
HELIX 3 AA3 LYS A 309 ASN A 322 1 14
HELIX 4 AA4 SER A 351 THR A 359 1 9
HELIX 5 AA5 ASP A 362 ASN A 383 1 22
HELIX 6 AA6 LYS A 391 ASP A 393 5 3
HELIX 7 AA7 ALA A 432 THR A 437 1 6
HELIX 8 AA8 PRO A 443 GLY A 460 1 18
HELIX 9 AA9 ASN A 468 GLY A 480 1 13
HELIX 10 AB1 ASN A 486 LEU A 490 5 5
HELIX 11 AB2 SER A 491 LEU A 502 1 12
HELIX 12 AB3 SER A 511 LEU A 516 1 6
HELIX 13 AB4 GLN A 517 ALA A 524 5 8
HELIX 14 AB5 PRO A 526 SER A 529 5 4
HELIX 15 AB6 LEU A 530 THR A 541 1 12
HELIX 16 AB7 LEU B 311 ASN B 322 1 12
HELIX 17 AB8 SER B 351 THR B 359 1 9
HELIX 18 AB9 ASP B 362 ASN B 383 1 22
HELIX 19 AC1 LYS B 391 ASP B 393 5 3
HELIX 20 AC2 THR B 415 SER B 419 5 5
HELIX 21 AC3 THR B 427 MET B 431 5 5
HELIX 22 AC4 ALA B 432 THR B 437 1 6
HELIX 23 AC5 PRO B 443 GLY B 460 1 18
HELIX 24 AC6 ASN B 468 GLY B 480 1 13
HELIX 25 AC7 ASN B 486 LEU B 490 5 5
HELIX 26 AC8 SER B 491 LEU B 502 1 12
HELIX 27 AC9 SER B 511 LEU B 516 1 6
HELIX 28 AD1 GLN B 517 ALA B 524 5 8
HELIX 29 AD2 PRO B 526 SER B 529 5 4
HELIX 30 AD3 LEU B 530 THR B 541 1 12
SHEET 1 AA1 5 TYR A 270 GLY A 277 0
SHEET 2 AA1 5 THR A 283 ASP A 289 -1 O VAL A 284 N ILE A 276
SHEET 3 AA1 5 GLU A 295 MET A 301 -1 O GLN A 300 N THR A 283
SHEET 4 AA1 5 GLU A 339 GLU A 345 -1 O MET A 344 N ALA A 297
SHEET 5 AA1 5 TYR A 330 VAL A 336 -1 N LEU A 331 O VAL A 343
SHEET 1 AA2 2 ILE A 395 LEU A 397 0
SHEET 2 AA2 2 VAL A 403 LEU A 405 -1 O LYS A 404 N LEU A 396
SHEET 1 AA3 5 GLU B 274 LYS B 275 0
SHEET 2 AA3 5 TYR B 285 ALA B 287 -1 O THR B 286 N GLU B 274
SHEET 3 AA3 5 VAL B 296 ILE B 298 -1 O VAL B 296 N ALA B 287
SHEET 4 AA3 5 VAL B 343 GLU B 345 -1 O MET B 344 N ALA B 297
SHEET 5 AA3 5 TYR B 330 ASP B 332 -1 N ASP B 332 O VAL B 343
SHEET 1 AA4 2 VAL B 385 ILE B 386 0
SHEET 2 AA4 2 ALA B 412 GLN B 413 -1 O ALA B 412 N ILE B 386
SHEET 1 AA5 2 ILE B 395 LEU B 397 0
SHEET 2 AA5 2 VAL B 403 LEU B 405 -1 O LYS B 404 N LEU B 396
LINK C SER A 422 N TPO A 423 1555 1555 1.34
LINK C TPO A 423 N MET A 424 1555 1555 1.33
LINK C SER B 422 N TPO B 423 1555 1555 1.36
LINK C TPO B 423 N MET B 424 1555 1555 1.35
SITE 1 AC1 11 GLU A 315 VAL A 318 MET A 319 ASN A 322
SITE 2 AC1 11 ILE A 327 VAL A 328 ASN A 383 HIS A 387
SITE 3 AC1 11 LEU A 405 THR A 406 GOL A 602
SITE 1 AC2 7 MET A 319 VAL A 328 MET A 344 THR A 406
SITE 2 AC2 7 ASP A 407 PHE A 408 4PV A 601
CRYST1 63.514 79.340 65.789 90.00 108.11 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015745 0.000000 0.005149 0.00000
SCALE2 0.000000 0.012604 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015992 0.00000